Effects of Piper sarmentosum water extract on 11-$ hydroxysteroid dehydrogenase type 1 bioactivity in ovariectomy-induced obese rats

International Journal of Pharmacology

Volumn 5, Issue 6, 2009, Pages 362-369

  Aida Azlina, A ^a   Farihah, H S ^a   Qodriyah, H M S ^a   Nur Azlina, M F ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

11 HSD1; Body weight; Obese; Ovariectomy; Piper sarmentosum

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ANTIOBESITY AGENT; GLYCYRRHIZIC ACID; PIPER SARMENTOSUM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HEART; INTRAABDOMINAL FAT; LIVER; NONHUMAN; OBESITY; OVARIECTOMY; PIPER SARMENTOSUM; PIPERACEAE; RAT; TREATMENT DURATION;

EID: 73449140759     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2009.362.369     Document Type: Article

References (41)

1. Agarwal, A.K., C. Monder, B. Eckstein and P.C. White, 1989. Cloning and expression of rat cDNA encoding corticosteroid 11beta-hydroxysteroid dehydrogenase. J. Biol. Chem., 264: 18939-18943.
2. Aida Azlina, A., S. Farihah, M.S. Qodriyah and M.F. Nur Azlina, 2009. Effects of Piper sarmentosum (Kaduk) water extract on adiponectin and blood glucose levels in ovariectomy-induced obese rats. Res. J. Med. Plants (In Press).
3. Alberts, P., L. Engblom, N. Edling, M. Forsgren and G. Klingstrom et al., 2002. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycemic mice. Diabetologia, 45: 1528-1532.
4. Alberts, P., L. Engblom, N. Edling, M. Forsgren and G. Klingstrom et al., 2003. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice. Endocrinology, 144: 4755-4762.
5. Al-Wahaibi, A., W.W.M. Nazaimoon, H.S. Farihah and A.L. Azian, 2007. Effects of water extract of Labisia pumila var alata on 11beta-hydroxysteroid dehydrogenase activity induced fat deposition in the Sprague Dawley rats. Trop. Med. Plants, 8: 21-26.
6. Armanini, D., D. Nacamulli, F. Francini-Pesenti, G. Battagin, E. Ragazzi and C. Fiore, 2005. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroid, 70: 538-542.
7. Asensio, C., P. Muzzin and F. Rohner-Jeanrenaud, 2004. Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistanee. Int. J. Obes. Relat. Metab. Disord., 28: 45-52.
8. Berger, J., M. Tanem, A. Elbrechet, A. Hermanowski-Vosatka, D.E. Moller, S.D. Wright and R. Thieringer, 2001. Peroxisome proliferators-activated receptor-ā ligand inhibited adipocytes 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem., 276: 12629-12635.
9. Björntop, P., 1991. Adipose tissue distribution and function. Int. J. Obes., 15: 67-81.
10. Brereton, P.S., R.R.V. Oriel, F.R. Suhaimi, K. Koyama, R. Dilley and Z. Krozowski, 2001. Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type 1 enzyme in the rat. Endocrinology, 142: 1644-1651.
11. Chu, S.C., Y.C. Chou, J.V. Liu, C.H. Chen, J.C. Shyu and F.P. Chou, 1999. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci., 64: 2299-2306.
12. Edwards, C.R., P.M. Stewart, D. Burt, L. Brett and M.A. McIntyre, 1988. Localization of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet, 2: 986-989.
13. Fried, S.K., C.D. Russell, N.L. Grauso and R.E. Brolin, 1993. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissue of obese women and men. J. Clin. Invest., 92: 2191-2198.
14. Funder, J.W., P.T. Pearce, R. Smith and A.I. Smith, 1988. Mineralocorticoid action: Target tissue specificity is enzyme, but not receptor, mediated. Science, 242: 583-585.
15. Gallagher, D., M. Visser and D. Sepulveda, 1996. How useful is body mass index for comparison of body fatness across age, sex and ethnic group? Am. J. Epidemiol., 143: 228-229.
16. Hauner, H., G. Entenmann, M. Wabitsch, D. Gaillard, G. Ailhaud, R. Negrel and E.F. Pfeiffer, 1989. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest., 84: 1663-1670.
17. Heikens, J., E. Fliers, E. Endert, M. Ackerman and G. van Montfrans, 1995. Liquorice-induced hypertension: A new understanding of an old disease: Case report and brief review. Neth. J. Med., 47: 230-234.
18. Heymsfield, S.B., D. Gallagher, E.T. Poehlman, C. Wolper, K. Nonas, D. Nelson and Z.M. Wang, 1994. Menopausal changes in body composition and energy expenditure. Exp. Gerontol., 29: 377-389.
19. Kano, S. and M. Doi, 2006. NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, accelerates the expression of UCP3 messenger RNA and ameliorates obesity in ovariectomized rats. Metabol. Clin. Exp., 55: 151-158.
20. Katz, J.R., V. Mohamed-Ali, P.J. Wood, J.S. Yudkin and S.W. Coppack, 1999. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin. Endocrinol. (Oxf.), 50: 63-68.
21. Kotelevtsev, Y., M.C. Holmes, A. Burchell, P.M. Houston and D. Schmoll et al., 1997. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA., 94: 14924-14929.
22. Krozowski, Z.S. and J.W. Funder, 1983. Renal mineralocorticoid receptors and hippocampal corticosteroid binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. USA., 80: 6056-6060.
23. Krozowski, Z.S., V. Obeyesekere, R. Smith and W. Mercer, 1992. Tissue-specific expression of an 11beta-hydroxysteroid dehydrogenase with a truncated N-terminal domain. A potential mechanism for differential intracellular localization within mineralcorticoid target cells. J. Biol. Chem., 267: 2569-2574.
24. Livingstone, D.E.W., G.C. Jones, K. Smith, R. Andrew, C.J. Kenyon and B.R. Walker, 2000. Understanding the role of glucocorticoids in obesity: Tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology, 141: 560-563.
25. Low, S.C., S.N. Assard, V. Rajan, K.E. Chapman, C.R. Edwards and J.R. Seckl, 1993. Regulation of 11beta-hydroxysteroid dehydrogenase by sex steroids in vivo: Further evidence for the existence of a second dehydrogenase in rat kidney. J. Endocrinol., 139: 27-35.
26. Masuzaki, H., J. Peterson, H. Shinyama, N.M. Morton, J.J. Mullins, J.R. Seckl and E.S. Flier, 2001. A transgenic model of visceral obesity and the metabolic syndrome. Science, 294: 2166-2170.
27. Masuzaki, H., H. Yamamoto, C.J. Kenyon, J.K. Elmquist and N.M. Morton., 2003. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Invest., 112: 83-90.
28. Monder, C., P.M. Stewart, V. Lakshmi, R. Valentino, D. Burt and C.R. Edwards, 1989. Licorice inhibits corticosteroid 11beta-HSD of rat kidney and liver in vivo and in vitro studies. Endocrinology, 125: 1046-1053.
29. Morton, N.M., M.C. Holmes, C. Fievet, B. Staels, A. Tailleux, J.J. Mullins and J.R. Seckl, 2001. Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem., 276: 41293-41300.
30. Paulmyer-Lacroix, O., S. Boullu, C. Oliver, M.C. Alessi and M. Grino, 2002. Expression of the messenger RNA coding for 11beta-HSD type 1 in adipose tissue from obese patients: An in situ hybridization study. J. Clin. Endocrinol. Metab., 87: 2701-2705.
31. Peterson, J.M., J.R. Seckl and J.J. Mullins, 2005. Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 289: 642-652.
32. Peungvicha, P., S.S. Thirawarapan, R. Temsiririrkkul, H. Watanabe, J.K. Prasain and S. Kodata, 1998. Hypoglycemic effect of the water extract of Piper sarmentosum in rats. J. Ethnopharmacol., 60: 27-32.
33. Poehlman, E.T., M.J. Toth and A.W. Gardner, 1995. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann. Int. Med., 123: 673-675.
34. Rask, E., T. Olsson, S. Soderberg, R. Andrew, D.E.W. Livingstone, O. Johnson and B.R. Walker, 2001. Tissue-specific deregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab., 86: 1418-1421.
35. Rask, E., B.K. Walker, S. Soderberg, D.E.W. Livingstone and M. Eliasson, 2002. Tissue specific changes in peripheral cortisol metabolism in obese women: Increased adipose 11beta-HSD type 1 activity. J. Clin. Endocrinol. Metab., 87: 3330-3336.
36. Reubinoff, B.E., J. Wurtman and L. Rojanski, 1995. Effects of hormone replacement therapy on weight, body fat composition, fat distribution and food intake in early postmenopausal women: A prospective study. Fertil. Steril., 64: 963-968.
37. Rosmond, R., 2005. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendorcrinology, 30: 1-10.
38. Stewart, P.M. and Z.S. Krozowski, 1999. 11beta Hydroxysteroid dehydrogenase. Vitam. Horm., 57: 249-324.
39. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes and J.A. Abraham, 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954.
40. Tomlinson, J.W., 2005. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: A novel therapeutic target. Minerva. Endocrinol., 30: 37-46.
41. Wang, M., 2006. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome. Curr. Opin. Invest. Drugs, 7: 319-323.